CN114617831A - 一种含番红花成分的安肤霜及其制备方法 - Google Patents
一种含番红花成分的安肤霜及其制备方法 Download PDFInfo
- Publication number
- CN114617831A CN114617831A CN202210321140.3A CN202210321140A CN114617831A CN 114617831 A CN114617831 A CN 114617831A CN 202210321140 A CN202210321140 A CN 202210321140A CN 114617831 A CN114617831 A CN 114617831A
- Authority
- CN
- China
- Prior art keywords
- parts
- oil
- skin
- peg
- saffron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000124209 Crocus sativus Species 0.000 title claims abstract description 26
- 235000015655 Crocus sativus Nutrition 0.000 title claims abstract description 26
- 235000013974 saffron Nutrition 0.000 title claims description 14
- 239000004248 saffron Substances 0.000 title claims description 14
- 239000002884 skin cream Substances 0.000 title claims description 14
- 238000002360 preparation method Methods 0.000 title description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 28
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000003921 oil Substances 0.000 claims abstract description 19
- 235000019198 oils Nutrition 0.000 claims abstract description 19
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 18
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000006071 cream Substances 0.000 claims abstract description 15
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims abstract description 11
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims abstract description 11
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims abstract description 11
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000010446 mineral oil Nutrition 0.000 claims abstract description 11
- 239000002480 mineral oil Substances 0.000 claims abstract description 11
- 229940100460 peg-100 stearate Drugs 0.000 claims abstract description 11
- 229930003799 tocopherol Natural products 0.000 claims abstract description 11
- 239000011732 tocopherol Substances 0.000 claims abstract description 11
- XYTHHAXRVHHXKO-JIUYZRCGSA-N 18-[(2r,3s,4r,5r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxyoctadecanoic acid;ethanol Chemical compound CCO.COC1O[C@H](CO)[C@@H](OCCCCCCCCCCCCCCCCCC(O)=O)[C@H](O)[C@H]1O XYTHHAXRVHHXKO-JIUYZRCGSA-N 0.000 claims abstract description 10
- 229960001295 tocopherol Drugs 0.000 claims abstract description 10
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 10
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 10
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 9
- 150000002339 glycosphingolipids Chemical class 0.000 claims abstract description 9
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 9
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003240 coconut oil Substances 0.000 claims abstract description 8
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 7
- 239000001140 aloe barbadensis leaf extract Substances 0.000 claims abstract description 7
- 239000000787 lecithin Substances 0.000 claims abstract description 7
- 235000010445 lecithin Nutrition 0.000 claims abstract description 7
- 229940067606 lecithin Drugs 0.000 claims abstract description 7
- 235000020238 sunflower seed Nutrition 0.000 claims abstract description 7
- 229940064064 purslane extract Drugs 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 229920001577 copolymer Polymers 0.000 claims description 18
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- SCVVSSZVLZQUDZ-UHFFFAOYSA-N 3-methyl-2,6-dihydro-1H-pyrimidine-2-carboxylic acid Chemical compound CN1C(NCC=C1)C(=O)O SCVVSSZVLZQUDZ-UHFFFAOYSA-N 0.000 claims description 11
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 229940075529 glyceryl stearate Drugs 0.000 claims description 10
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 9
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 229940047670 sodium acrylate Drugs 0.000 claims description 9
- 230000001804 emulsifying effect Effects 0.000 claims description 8
- 239000010651 grapefruit oil Substances 0.000 claims description 8
- 244000234609 Portulaca oleracea Species 0.000 claims description 7
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 7
- 229940069638 aloe vera leaf extract Drugs 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 6
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 6
- 229960002216 methylparaben Drugs 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 229940035437 1,3-propanediol Drugs 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 5
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 4
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 4
- 238000004945 emulsification Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229940068968 polysorbate 80 Drugs 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 2
- 229950008882 polysorbate Drugs 0.000 claims description 2
- 235000004237 Crocus Nutrition 0.000 claims 2
- 241000596148 Crocus Species 0.000 claims 2
- -1 caprylyl hydroxamic Chemical compound 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 230000008591 skin barrier function Effects 0.000 abstract description 2
- OTPDWCMLUKMQNO-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine Chemical compound C1NCC=CN1 OTPDWCMLUKMQNO-UHFFFAOYSA-N 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 244000144927 Aloe barbadensis Species 0.000 description 6
- 235000002961 Aloe barbadensis Nutrition 0.000 description 6
- 235000011399 aloe vera Nutrition 0.000 description 6
- 244000060011 Cocos nucifera Species 0.000 description 5
- 235000013162 Cocos nucifera Nutrition 0.000 description 5
- 229930003427 Vitamin E Natural products 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 230000035483 skin reaction Effects 0.000 description 3
- 231100000430 skin reaction Toxicity 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000208818 Helianthus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- GLCCKUUEBRLFTH-UHFFFAOYSA-N COCOS Chemical compound COCOS GLCCKUUEBRLFTH-UHFFFAOYSA-N 0.000 description 1
- 241000737241 Cocos Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- HGINCPLSRVDWNT-UHFFFAOYSA-N acrylaldehyde Natural products C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical & Material Sciences (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及一种含番红花成分的安肤霜，由包括以下重量百分比的组分制成：甘油4～8、肉豆蔻酸异丙酯2～4.5、异十六烷2～4.5、环五聚二甲基硅氧烷1～3、环己硅氧烷1～3、库拉索芦荟叶提取物1～3.5、CB69615830.1～0.3、丁二醇0.15～0.4、CB8964533 0.2～0.5、甘油硬脂酸酯1～2、矿油3～7、椰子油1～2.5、PEG‑20甲基葡糖倍半硬脂酸酯0.75～2.15、1,3‑丙二醇2～4、PEG‑100硬脂酸酯0.5～1.5、生育酚0.1～0.4、1,2‑己二醇0.3～0.7、糖鞘脂类0.1～0.3、聚山梨醇酯‑80 0.6～0.9、向日葵籽油0.01～0.05、辛酰羟肟酸0.02～0.06、卵磷脂0.05～0.1、马齿苋提取物0.1～0.2、番红花提取物0.1～0.4、四氢甲基嘧啶羧酸0.02～0.05、防腐剂0.2～0.5、余量为水。本发明具有快速修复肌肤敏感问题，重建肌肤屏障的优点。
Description
技术领域
本发明属于化妆品领域，具体地说，是一种安肤面霜及其制备方法。
背景技术
敏感肌是由皮肤受到外界环境或化妆品的侵害产生的过度皮肤反应，出现面部紧绷，干燥，红肿，痒痛，刺激等现象，严重影响了当代人的生活质量。而引起敏感肌的源头全是由很多个方面造成的，比如日光损伤、环境污染、化学刺激、色素沉着、油性痤疮肌肤、高压生活方式、炎症衰老等各个方面。随着年龄的增加，不饱和脂肪酸在肌肤细胞间质的含量会大量流失，植物油可以很好的帮助其恢复其正常水平，从而保湿肌肤的屏障作用，减少透皮失水，目前由于大多数化妆品由多种组分混合，防腐，防过敏，乳化剂，保持各组分本身的功能及加强各组分之间的组合效果，同时现有多为添加水溶性或者精油类的舒缓产品，而水溶性物质由于渗透性强，对于已经敏感受损的肌肤刺激性较大，全精油类产品呈现液态不易运输及保存且容易氧化酸败，失去活性；为此，我们提出一种具有舒缓修复敏感肌肤的安肤膏。
发明内容
本发明针对现有技术的不足之处，解决皮肤因过敏引起的不适，本发明的第一目的是提供一种以番红花(CROCUS SATIVUS)提取物和四氢甲基嘧啶羧酸配伍的安肤霜。
本发明的第二目的是提供该安肤霜的制备方法。
为解决上述的技术问题，本发明采用如下技术方案：一种含番红花成分的安肤霜，由包括以下重量百分比的组分制成：
甘油4～8、肉豆蔻酸异丙酯2～4.5、异十六烷2～4.5、环五聚二甲基硅氧烷1～3、环己硅氧烷1～3、库拉索芦荟(ALOE BARBADENSIS)叶提取物1～3.5、丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物(CBNumber:CB6961583)0.1～0.3、丁二醇0.15～0.4、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物(CBNumber:CB8964533)0.2～0.5、甘油硬脂酸酯1～2、矿油3～7、椰子(COCOS NUCIFERA)油1～2.5、PEG-20甲基葡糖倍半硬脂酸酯0.75～2.15、1,3-丙二醇2～4、PEG-100硬脂酸酯0.5～1.5、生育酚(维生素E)0.1～0.4、1,2-己二醇0.3～0.7、糖鞘脂类0.1～0.3、聚山梨醇酯-80 0.6～0.9、向日葵(HELIANTHUS ANNUUS)籽油0.01～0.05、辛酰羟肟酸0.02～0.06、卵磷脂0.05～0.1、马齿苋(PORTULACA OLERACEA)提取物0.1～0.2、番红花(CROCUS SATIVUS)提取物0.1～0.4、四氢甲基嘧啶羧酸0.02～0.05、防腐剂0.2～0.5、余量为水。其中，所述水采用去离子水或蒸馏水。
本方案采用甘油、肉豆蔻酸异丙酯、异十六烷、环五聚二甲基硅氧烷、环己硅氧烷、甘油硬脂酸酯、矿油、椰子油、1,3-丙二醇及PEG-100硬脂酸酯等作为油相基底，具有很好的保湿润肤功效，且原料经济便宜，无毒副作用；再配以番红花(CROCUS SATIVUS)提取物和四氢甲基嘧啶羧酸配伍的多种皮肤调理剂，可改善皮肤血液循环、促进皮肤新陈代谢、清除自由基、抑制黑色素沉积、加速消斑脱色、吸收紫外线等，发挥美白、防晒、抗衰老的功效，并且对接触性皮炎、溢脂性皮炎、瘙痒症、神经性皮炎有治疗作用，最后配合糖鞘脂类、生育酚、卵磷脂等皮肤调理剂，增强产品的保湿、抗敏、抗氧化、修复、美白等功效。
优选的，所述防腐剂采用羟苯甲酯。
优选的，还包括有着色剂0.01～0.02，其中，所述着色剂采用CI19140(柠檬黄)。
优选的，还包括有香精0.01～0.05，所述香精采用葡萄柚油，葡萄柚油不仅起到增香作用，还能对皮肤起到很好的清洁和保养作用。
优选的，安肤霜的最优组分为：甘油5、肉豆蔻酸异丙酯3、异十六烷3、环五聚二甲基硅氧烷2、环己硅氧烷2、库拉索芦荟(ALOE BARBADENSIS)叶提取物2、丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物0.2、丁二醇0.2、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.3、甘油硬脂酸酯1、矿油5、椰子(COCOS NUCIFERA)油1、PEG-20甲基葡糖倍半硬脂酸酯1、1,3-丙二醇3、PEG-100硬脂酸酯1、生育酚(维生素E)0.2、羟苯甲酯0.2、1,2-己二醇0.5、糖鞘脂类0.1、聚山梨醇酯-80 0.6、向日葵(HELIANTHUS ANNUUS)籽油0.01、香精0.03、辛酰羟肟酸0.02、卵磷脂0.05、马齿苋(PORTULACA OLERACEA)提取物0.1、番红花(CROCUS SATIVUS)提取物0.1、四氢甲基嘧啶羧酸0.02、CI19140 0.01、余量为水。
本发明还公开一种上述安肤霜的制备方法，包括的步骤如下：
S1.准确称量配方中各种原料,用干净并消毒好的器皿盛放；
S2.将所述丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物、丁二醇、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、PEG-20甲基葡糖倍半硬脂酸酯、生育酚、糖鞘脂类、1,2-己二醇、聚山梨醇酯-80、羟苯甲酯及水加入真空乳化锅，将所述甘油、肉豆蔻酸异丙酯、异十六烷、环五聚二甲基硅氧烷、环己硅氧烷、甘油硬脂酸酯、矿油、椰子油、1,3-丙二醇及PEG-100硬脂酸酯加入真空油相锅，分别升温至80-85℃，搅拌均匀并使其完全溶解，保温5-7分钟；
S4.降温至65-70℃，将所述库拉索芦荟叶提取物、向日葵籽油、马齿苋提取物、番红花提取物及真空油相锅中的原料加入真空乳化锅内，搅拌至完全均匀，保温5-7分钟；
S5.降温至40-45℃，加入四氢甲基嘧啶羧酸和香精到真空乳化锅内，搅拌至完全均匀，保温3-5分钟；
S6.降温至35-38℃时,出料、静置。
与现有技术相比，本发明具有如下有益效果：本发明组分配方温和无刺激，具有协同增效，添加多种植萃精油，以油养肤，及给肌肤提供营养，对皮肤的渗透性好，具有快速修复肌肤敏感问题，重建肌肤屏障的优点。
具体实施例
为了更好地阐述本发明内容，下面用若干较佳的具体实施例进行说明。但这些具体实施例只是为了说明本发明的内容，而不是对本发明内容进行限制。
一种含番红花成分的安肤霜，由包括以下重量百分比的组分制成：由包括以下重量百分比的组分制成：
甘油4～8、肉豆蔻酸异丙酯2～4.5、异十六烷2～4.5、环五聚二甲基硅氧烷1～3、环己硅氧烷1～3、库拉索芦荟(ALOE BARBADENSIS)叶提取物1～3.5、丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物0.1～0.3、丁二醇0.15～0.4、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.2～0.5、甘油硬脂酸酯1～2、矿油3～7、椰子(COCOS NUCIFERA)油1～2.5、PEG-20甲基葡糖倍半硬脂酸酯0.75～2.15、1,3-丙二醇2～4、PEG-100硬脂酸酯0.5～1.5、生育酚(维生素E)0.1～0.4、1,2-己二醇0.3～0.7、糖鞘脂类0.1～0.3、聚山梨醇酯-800.6～0.9、向日葵(HELIANTHUS ANNUUS)籽油0.01～0.05、辛酰羟肟酸0.02～0.06、卵磷脂0.05～0.1、马齿苋(PORTULACA OLERACEA)提取物0.1～0.2、番红花(CROCUS SATIVUS)提取物0.1～0.4、四氢甲基嘧啶羧酸0.02～0.05、防腐剂0.2～0.5、余量为水。其中，所述水采用去离子水或蒸馏水。
优选的，所述防腐剂采用羟苯甲酯。
优选的，还包括有着色剂0.01～0.02，其中，所述着色剂采用CI19140(柠檬黄)。
优选的，还包括有香精0.01～0.05，所述香精采用葡萄柚油，葡萄柚油不仅起到增香作用，还能对皮肤起到很好的清洁和保养作用。
本发明还公开一种上述安肤霜的制备方法，包括的步骤如下：
S1.准确称量配方中各种原料,用干净并消毒好的器皿盛放；
S2.将所述丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物、丁二醇、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、PEG-20甲基葡糖倍半硬脂酸酯、生育酚、糖鞘脂类、1,2-己二醇、聚山梨醇酯-80、羟苯甲酯及水加入真空乳化锅，将所述甘油、肉豆蔻酸异丙酯、异十六烷、环五聚二甲基硅氧烷、环己硅氧烷、甘油硬脂酸酯、矿油、椰子油、1,3-丙二醇及PEG-100硬脂酸酯加入真空油相锅，分别升温至80-85℃，搅拌均匀并使其完全溶解，保温5-7分钟；
S4.降温至65-70℃，将所述库拉索芦荟叶提取物、向日葵籽油、马齿苋提取物、番红花提取物及真空油相锅中的原料加入真空乳化锅内，搅拌至完全均匀，保温5-7分钟；
S5.降温至40-45℃，加入四氢甲基嘧啶羧酸和葡萄柚油到真空乳化锅内，搅拌至完全均匀，保温3-5分钟；
S6.降温至35-38℃时,出料、静置。
实施例1
其制备方法如下：
S1.准确称量配方中各种原料,用干净并消毒好的器皿盛放；
S2.将所述丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物、丁二醇、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、PEG-20甲基葡糖倍半硬脂酸酯、生育酚、糖鞘脂类、1,2-己二醇、聚山梨醇酯-80、羟苯甲酯及水加入真空乳化锅，将所述甘油、肉豆蔻酸异丙酯、异十六烷、环五聚二甲基硅氧烷、环己硅氧烷、甘油硬脂酸酯、矿油、椰子油、1,3-丙二醇及PEG-100硬脂酸酯加入真空油相锅，分别升温至80-85℃，搅拌均匀并使其完全溶解，保温5-7分钟；
S4.降温至65-70℃，将所述库拉索芦荟叶提取物、向日葵籽油、马齿苋提取物、番红花提取物及真空油相锅中的原料加入真空乳化锅内，搅拌至完全均匀，保温5-7分钟；
S5.降温至40-45℃，加入四氢甲基嘧啶羧酸和葡萄柚油到真空乳化锅内，搅拌至完全均匀，保温3-5分钟；
S6.降温至35-38℃时,出料、静置。
实施例2
其制备方法参考类同实施例1。
安全性、功效性评价试验
本发明安肤霜的安全性和功效性评估如下：
安肤霜的安全性测试方法：分别选30名试用者进行实施例1和实施例2的安肤霜产品进行斑贴试验，通过肉眼观察，24小时后观察皮肤反应：
| 反应程度 | 皮肤反应 |
| 0 | 无不良反应 |
| 1 | 仅有微弱红斑 |
| 2 | 发生红斑反应 |
| 3 | 发生疱疹反应 |
| 4 | 发生融合性疱疹反应 |
经过斑贴实验，上述实施例1和实施例2的试用者均无不良反应。
安肤霜的功效性测试为选择20名患有皮肤过敏的试用者进行实施例1和实施例2的安肤霜产品的涂抹试验，首先，用VISIA机进行拍摄面部在没有使用产品前的及使用产品一周后进行对比；经试验后，试用者面部过敏区域的红斑数量明显减少，证明本产品对修护肌肤的细微损伤，强健表层保湿屏障有明显功效。
值得注意的是，本发明使用的原料和试剂的来源均为市售，本发明未注明具体条件的实验方法，通常按照常规条件进行，或厂商建议的条件进行。
上述实施例为本发明较佳的实施方式，但本发明的实施方式并不受上述实施例的限制，其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化，均应为等效置换方式，都包含在本发明的保护范围之内。
Claims (9)
1.一种含番红花成分的安肤霜，其特征在于，由包括以下重量百分比的组分制成：甘油4～8、肉豆蔻酸异丙酯2～4.5、异十六烷2～4.5、环五聚二甲基硅氧烷1～3、环己硅氧烷1～3、库拉索芦荟叶提取物1～3.5、丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物0.1～0.3、丁二醇0.15～0.4、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.2～0.5、甘油硬脂酸酯1～2、矿油3～7、椰子油1～2.5、PEG-20甲基葡糖倍半硬脂酸酯0.75～2.15、1,3-丙二醇2～4、PEG-100硬脂酸酯0.5～1.5、生育酚0.1～0.4、1,2-己二醇0.3～0.7、糖鞘脂类0.1～0.3、聚山梨醇酯-80 0.6～0.9、向日葵籽油0.01～0.05、辛酰羟肟酸0.02～0.06、卵磷脂0.05～0.1、马齿苋提取物0.1～0.2、番红花提取物0.1～0.4、四氢甲基嘧啶羧酸0.02～0.05、防腐剂0.2～0.5、余量为水。
2.根据权利要求1所述的一种含番红花成分的安肤霜，其特征在于：所述防腐剂采用羟苯甲酯。
3.根据权利要求1所述的一种含番红花成分的安肤霜，其特征在于：还包括有着色剂0.01～0.02。
4.根据权利要求3所述的一种含番红花成分的安肤霜，其特征在于：所述着色剂采用CI19140。
5.根据权利要求1所述的一种含番红花成分的安肤霜，其特征在于：还包括有香精0.01～0.05。。
6.根据权利要求5所述的一种含番红花成分的安肤霜，其特征在于：所述香精采用葡萄柚油。
7.根据权利要求1所述的一种含番红花成分的安肤霜，其特征在于，由包括以下重量百分比的组分制成：甘油5、肉豆蔻酸异丙酯3、异十六烷3、环五聚二甲基硅氧烷2、环己硅氧烷2、库拉索芦荟叶提取物2、丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物0.2、丁二醇0.2、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.3、甘油硬脂酸酯1、矿油5、椰子油1、PEG-20甲基葡糖倍半硬脂酸酯1、1,3-丙二醇3、PEG-100硬脂酸酯1、生育酚0.2、羟苯甲酯0.2、1,2-己二醇0.5、糖鞘脂类0.1、聚山梨醇酯-80 0.6、向日葵籽油0.01、香精0.03、辛酰羟肟酸0.02、卵磷脂0.05、马齿苋提取物0.1、番红花提取物0.1、四氢甲基嘧啶羧酸0.02、CI19140 0.01、余量为水。
8.根据权利要求1或7所述的一种含番红花成分的安肤霜，其特征在于，所述水采用去离子水或蒸馏水。
9.根据权利要求1-7任一所述的一种含番红花成分的安肤霜的制备方法，其特征在于，步骤如下：
S1.准确称量配方中各种原料,用干净并消毒好的器皿盛放；
S2.将所述丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物、丁二醇、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、PEG-20甲基葡糖倍半硬脂酸酯、生育酚、糖鞘脂类、1,2-己二醇、聚山梨醇酯-80、羟苯甲酯及水加入真空乳化锅，将所述甘油、肉豆蔻酸异丙酯、异十六烷、环五聚二甲基硅氧烷、环己硅氧烷、甘油硬脂酸酯、矿油、椰子油、1,3-丙二醇及PEG-100硬脂酸酯加入真空油相锅，分别升温至80-85℃，搅拌均匀并使其完全溶解，保温5-7分钟；
S4.降温至65-70℃，将所述库拉索芦荟叶提取物、向日葵籽油、马齿苋提取物、番红花提取物及真空油相锅中的原料加入真空乳化锅内，搅拌至完全均匀，保温5-7分钟；
S5.降温至40-45℃，加入四氢甲基嘧啶羧酸和葡萄柚油到真空乳化锅内，搅拌至完全均匀，保温3-5分钟；
S6.降温至35-38℃时,出料、静置。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210321140.3A CN114617831A (zh) | 2022-03-29 | 2022-03-29 | 一种含番红花成分的安肤霜及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210321140.3A CN114617831A (zh) | 2022-03-29 | 2022-03-29 | 一种含番红花成分的安肤霜及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114617831A true CN114617831A (zh) | 2022-06-14 |
Family
ID=81904021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210321140.3A Pending CN114617831A (zh) | 2022-03-29 | 2022-03-29 | 一种含番红花成分的安肤霜及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114617831A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116919867A (zh) * | 2023-07-20 | 2023-10-24 | 广州市精锐生物研究有限公司 | 一种美白遮瑕抗紫外线的组合物及其制备方法和应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108379160A (zh) * | 2018-04-20 | 2018-08-10 | 安徽怡人生物科技有限公司 | 一种祛斑美白霜及其制备方法 |
| CN112641653A (zh) * | 2021-02-05 | 2021-04-13 | 东晟源研究院(广州)有限公司 | 具有排浊功能的深层清洁按摩霜的配方及制备方法 |
-
2022
- 2022-03-29 CN CN202210321140.3A patent/CN114617831A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108379160A (zh) * | 2018-04-20 | 2018-08-10 | 安徽怡人生物科技有限公司 | 一种祛斑美白霜及其制备方法 |
| CN112641653A (zh) * | 2021-02-05 | 2021-04-13 | 东晟源研究院(广州)有限公司 | 具有排浊功能的深层清洁按摩霜的配方及制备方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116919867A (zh) * | 2023-07-20 | 2023-10-24 | 广州市精锐生物研究有限公司 | 一种美白遮瑕抗紫外线的组合物及其制备方法和应用 |
| CN116919867B (zh) * | 2023-07-20 | 2024-05-14 | 广州市精锐生物研究有限公司 | 一种美白遮瑕抗紫外线的组合物及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110652481B (zh) | 一种透明质酸温和保湿洁面乳及其制备方法 | |
| CN110859762B (zh) | 含有山茶提取物的具有晒后修复功效的凝胶及其制备方法 | |
| CN111481475A (zh) | 一种改善女性荷尔蒙的可食性唇膏及其制备方法 | |
| CN114617831A (zh) | 一种含番红花成分的安肤霜及其制备方法 | |
| CN112641670A (zh) | 保湿精华乳及其制备方法 | |
| CN114099387B (zh) | 一种玫瑰美白保湿精华乳及其制备方法 | |
| CN114028277A (zh) | 一种具有舒缓修复敏感肌肤的安肤膏 | |
| KR101817514B1 (ko) | 헤스페레틴의 신규 용도 | |
| CN113995693A (zh) | 一种具有抗炎功效脂质体的精华液组合物及其制备方法和应用 | |
| CN114129479A (zh) | 有效快速缓解婴儿干性湿疹的组合物及制备方法与用途 | |
| CN108392455A (zh) | 含有铁皮石斛提取物的护肤霜及其制备方法 | |
| CN111494270A (zh) | 一种多效舒缓精华组合物与多效舒缓精华露及其制备方法 | |
| CN116115528A (zh) | 一种舒缓修护保湿组合物及其应用和制备方法 | |
| CN112999124B (zh) | 一种护眼喷雾及其制备方法 | |
| CN113576994A (zh) | 具有协同保湿舒缓效果的组合物、化妆品及其制备方法 | |
| CN114931532A (zh) | 一款以几种植物提取物为活性成分的舒缓镇敏的组合物 | |
| CN109431881B (zh) | 一种防皮肤干裂的藏绵羊油 | |
| CN113940896A (zh) | 含维A醇(Viga Retinol)的抗衰肌肤修复液及其制备方法 | |
| CN112402309A (zh) | 一种多维矿物精华霜及其制备方法 | |
| CN115721586B (zh) | 一种皮肤护理基质 | |
| CN108392454A (zh) | 含有铁皮石斛提取物的护肤乳及其制备方法 | |
| EP3909563B1 (de) | Kosmetische creme | |
| AU2021105954A4 (en) | Multi-purpose mineral bodywash | |
| CN115192471B (zh) | 一种可以改善皮肤弹性的纳米乳凝胶、化妆品组合物及其制备和应用 | |
| CN115154343B (zh) | 改善眼部松弛和黑眼圈的组合物、制剂及制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: 510000 room 415-1, building 1, Department of Guangdong University of pharmacy, No. 280, Waihuan East Road, Xiaoguwei street, Panyu District, Guangzhou, Guangdong Province Applicant after: Guangzhou Xinrui Pharmaceutical Biotechnology Co.,Ltd. Address before: 510000 room 415-1, building 1, Department of Guangdong University of pharmacy, No. 280, Waihuan East Road, Xiaoguwei street, Panyu District, Guangzhou, Guangdong Province Applicant before: Xinrui (Guangzhou) Brand Management Co.,Ltd. |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220614 |